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Abstract
Background—Inequalities in Neisseria gonorrhoeae (gonorrhea) burden by sexual minority 
status in the United States are difficult to quantify. Sex of sex partner is not routinely collected for 
reported cases. Population estimates of men who have sex with men (MSM) necessary to calculate 
case rates have not been available until recently. For these reasons, trends in reported gonorrhea 
rates among MSM have not been described across multiple jurisdictions.
Methods—We estimated of the number of MSM cases reported in 6 jurisdictions continuously 
participating in the STD Surveillance Network 2010–2015 based on interviews with a random 
sample of cases. Data were obtained for Baltimore, Philadelphia, New York City, San Francisco, 
California (excluding San Francisco), and Washington State. Estimates of the MSM, heterosexual 
male (MSW) and female populations were obtained from recently published estimates and census 
data. Case rates and rate-ratios were calculated comparing trends in reported cases among MSM, 
heterosexual males and women.
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Results—The proportion of male gonorrhea cases among MSM varied by jurisdiction (range: 
20% to 98%). Estimated MSM rate increased from 1369 cases per 100,000 in 2010 to 3435 cases 
per 100,000 in 2015. Between 2010 and 2015, the MSM-to-Women gonorrhea rate ratio increased 
from 13:1 to 24:1, and the MSM-to-MSW gonorrhea rate ratio increased from 16:1 to 31:1.
Conclusions—Estimated gonorrhea rate among MSM increased in a network of 6 
geographically diverse US jurisdictions. Estimating the size of this population, determining MSM 
among reported cases and estimating rates are essential first steps for better understanding the 
changing epidemiology of gonorrhea.
BACKGROUND
The rate of reported cases of Neisseria gonorrhoeae in the United States has been increasing 
since an historic low of 98.1 cases per 100,000 population in 2009.1 The rate among men 
recently surpassed that of women, with the reported case rate among men increasing 18% 
from 2014 to 2015 while the rate among women increased just 6% in the same time frame.1 
An increase in gonorrhea cases diagnosed and reported among gay, bisexual, and other men 
who have sex with men (MSM) is likely a contributing factor for the observed gender-
specific trend. Increases in the number of early syphilis cases reported among MSM1–3 
provides compelling evidence to suggest that MSM may be contributing to increases in 
gonorrhea as well. An effective public health response to increasing gonorrhea would likely 
require differential interventions depending on the relative contribution of MSM versus 
heterosexual men and women at the jurisdictional level.
Differences in disease rates by sexual minority status have historically been difficult to 
characterize. The lack of reliable data on the number of reported cases among MSM, as well 
as limited availability of population denominators for MSM, preclude reliably estimating 
case rates among MSM for most state and county-level jurisdictions in the United States. 
However, a previous study examining the incidence of human immunodeficiency virus 
(HIV) and syphilis among MSM in the United States using national-level estimates of the 
MSM population found significant differences between MSM, women, and men who have 
sex exclusively with women (MSW).4 Using national estimates of the size of the MSM 
population, the investigators calculated point estimates for incidence of HIV and primary 
and secondary syphilis at the national level, revealing significant differences in the burden of 
disease among MSM. Syphilis and HIV are conditions for which sex of sex partner 
information is well-ascertained through routine case surveillance for HIV cases and through 
partner management activities for syphilis cases.
Yet no similar data are available for gonorrhea at the national level. The gender of sex 
partners of persons diagnosed with gonorrhea is not routinely ascertained for the majority of 
reported cases in the United States, in large measure because the majority of reported 
gonorrhea cases are not interviewed for partner services. Most state and local health 
departments appropriately prioritize HIV and syphilis cases for partner services because of 
the severity of these infections. Only where additional capacity exists are partner services 
offered to persons diagnosed and reported with gonorrhea. Information about sex of sex 
partners for gonorrhea cases at the local level is generally available only for a limited subset 
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of patients, and likely constitutes a biased sample because local priorities established for 
targeting partner services differ widely.
To address gaps in MSM-related information available for persons diagnosed with 
gonorrhea, a sentinel surveillance project, the sexually transmitted disease (STD) 
Surveillance Network (SSuN), was established to support geographically diverse 
jurisdictions in conducting enhanced case investigations, including behavioral interviews, 
among a probability sample of reported gonorrhea cases.5 This project provides jurisdiction-
level estimates of the proportion of all reported cases among men who also report same sex 
partnerships, which have been used to estimate the overall number of cases reported among 
MSM. This information has been used nationally to inform CDC’s STD Surveillance 
reports1 and provides other outcomes of interest such as treatment regimens being used to 
treat persons diagnosed with gonorrhea. However, these data have not yet been used to 
examine trends in case rates because estimates of the size of the MSM population at the 
county level needed for rate calculations were not previously available. National estimates of 
the size of the MSM population, however accurate these may be, don’t address heterogeneity 
in MSM populations at the local level and are likely inappropriate to use for estimating rates 
at the state or county level. The ability to assess and compare population-specific gonorrhea 
rates for sexual minorities at the local level is essential to both understanding the changing 
epidemiology of gonorrhea as well as for developing appropriately targeted public health 
responses.
Estimates of the size of the MSM population at the state and county level for the entire 
United States have recently been published.6 With the availability of these denominator 
estimates, and data from SSuN on the proportion of gonorrhea cases attributable to MSM at 
the county level, we can now estimate the number and rate of gonorrhea diagnoses among 
MSM in 6 jurisdictions continuously participating in SSuN between 2010 and 2015. We 
compared trends in estimated case rates among MSM to women and to MSW to better 
quantify inequities in the burden of disease. To our knowledge, gonorrhea rates for MSM 
across multiple U.S. jurisdictions have not previously been published. Moreover, these 
findings may provide evidence to help interpret recent changes in observed gonorrhea cases 
elsewhere, suggest a rationale for refocusing STD prevention interventions where 




Surveillance coordinators in Baltimore City, California (excluding San Francisco, which is 
included separately), New York City, Philadelphia, San Francisco, and Washington State 
randomly sampled all gonorrhea cases that were diagnosed and reported in their jurisdictions 
in 2 SSuN project cycles 2010 to 2013 and for July through December 2015.We include only 
these 6 SSuN jurisdictions in our analysis because they collaborated continuously across 
multiple project cycles. Following common SSuN project protocols, patients in the random 
sample were contacted for interview. For the current analysis, we included only cases for 
persons 18 to 64 years of age at diagnosis to represent the sexually active adult population 
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and match available denominators. If a patient was reported with laboratory-confirmed 
infection in multiple anatomic sites simultaneously, they were counted only once as a single 
case of gonorrhea for calculation of case rates. Men who have sex with men were defined in 
our analysis as any man reporting male sex partners in the previous 3 months, reporting their 
sexual orientation as gay or bisexual, or identified as MSM by diagnosing providers. We 
chose to be as inclusive as possible in identifying male patients who do not identify as gay 
or report male partners so as not to exclude MSM who may have been unwilling to disclose 
when speaking to public health staff.7 Data from participating sites were collected as part of 
enhanced surveillance activities exempt from human subjects review; SSuN protocols were 
approved by the Office of Management and Budget (control 0920-0842 and 0920-1072) and 
did not include personal identifiers on individual patients. Data were not available for 2014 
due to the transition between separate SSuN project cycles.
Design weights were developed for interviewed cases accounting for sample fraction at the 
county level and adjusted for nonresponse by sex and age group of the patient. Final case 
weights were used to estimate the proportion of male gonorrhea cases occurring among men 
who are MSM by year for 2010 to 2013, and for 2015. The number of gonorrhea cases 
among women was obtained directly from reported morbidity and the number of MSW 
cases was obtained by subtracting the estimated number of MSM gonorrhea cases from the 
reported total of male cases.
The proportion of all men estimated to be MSM in each county was obtained from recently 
published estimates based on the American Community Survey 5-year summary file which 
provides a single point estimate for the 5-year period covered by the survey.6 The total 
county population of men and women between 18 and 64 years of age 2010 to 2013 and for 
2015 was obtained from U.S. Census Bureau intercensal projections.8 The total population 
of MSM aged 18 to 64 years for each year at the county level was calculated by multiplying 
the male population by the proportion estimated to be MSM from published estimates. 
Consistent with methods used to develop 5-year estimates of the MSM population, we 
assumed no change in this percentage over our study period. However, the number of MSM 
calculated for our denominator increased each year reflecting underlying population growth 
among all men. Similarly, population estimates for the MSW population were obtained by 
subtracting the estimated number of MSM from the total male population. Population of 
women was obtained directly from census projections. County-level estimates of the 
population of MSM, MSW, and women were summed to provide denominators for 
jurisdiction-level rate calculations for the participating SSuN sites.
Estimated Rates and Rate Ratios
Estimated annual gonorrhea case rates per 100,000 persons for 2010 to 2013 and for 2015 
were calculated for MSM, MSW, women and for total reported cases based on estimates of 
the number of cases occurring in each group using as the denominator the estimate of MSM 
in the population and population of women obtained directly from the census projection. 
Only 6 months of interview data were available for 2013, and again for 2015; we assumed 
that the proportion of male gonorrhea cases reporting MSM exposure in these half-year 
periods was representative of the entire year and used the full year of gonorrhea cases 
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reported to CDC in deriving the estimates of the number MSM and MSW cases for 2013 and 
2015. We calculate rate ratios by year for MSM, MSW and women to examine how MSM 
rates changed between these groups across the period.
RESULTS
Across the 6 SSuN jurisdictions contributing data to this analysis, a total of 306,949 cases of 
gonorrhea were reported among persons 18 to 64 years of age during the 2 analysis periods. 
Of 30,761 (10%) randomly sampled cases, we obtained information for 14,080 cases for an 
overall response rate of 45.7% (range across sites, 34.7%–64.9%). Across all 6 sites, overall 
reported gonorrhea case rate per 100,000 population increased 71.3% between 2010 and 
2015, from 130.8 to 224.1 cases per 100,000. There was a variation in the overall trends 
between sites; sharp increases were noted in SSuN sites on the west coast (Washington, San 
Francisco, and California) and in New York City. However gonorrhea case rates were 
relatively stable in Philadelphia and decreased slightly in Baltimore between 2010 and 2015 
(Table 1).
Unweighted analysis of cases among MSM reveal that 49.5% are between 20 and 29 years 
of age, 25.2% between 30 and 39 years of age, 39.9% are non-Hispanic White, 25.7% are 
non-Hispanic Black, and 24.6% report Hispanic ethnicity. Among these men, 14.0% also 
report having both male and female sex partners and 22.8% report being HIV-positive at the 
time of the interview. Based on weighted analysis across the entire study period, we 
estimated that 57.3% of all reported male cases occurred among MSM.
The weighted proportion of male gonorrhea cases estimated to occur among MSM varied by 
SSuN site and by year with a range of 20.3% in Philadelphia in 2010 to 97.6% in San 
Francisco in 2013. For 2015, the weighted proportion of cases among MSM across all 6 
SSuN sites was 67.8% (range, 32.0%–92.5%). The total estimated number of cases among 
MSM by year in these 6 sites more than doubled from 13,766 in 2010 to 36,265 in 2015 
(Table 1). This represents a 163% increase in the estimated number of gonorrhea cases 
among MSM, whereas reported cases among women increased by 45% in the same time 
frame.
Based on estimates of the MSM population in each jurisdiction, the calculated rate of 
reported gonorrhea cases per 100,000 among MSM increased overall, and for individual 
sites, from 2010 to 2015. The estimated rate of gonorrhea among MSM across all sites in 
2010 was 1368.5 cases per 100,000 and more than doubled to 3434.7 per 100,000 in 2015. 
There were significant differences in the annual rates among MSM between SSuN sites, but 
in general, the rates for full-state jurisdictions participating in SSuN (Washington and 
California) were lower than for the city-level jurisdictions. The lowest estimated MSM rate 
across SSuN sites during the study period was 1079 cases per 100,000 in Washington State 
in 2011 and the highest estimated rate was 6169 cases per 100,000 in San Francisco in 2015.
The estimated rate for MSW across all sites increased from 84.3 cases per 100,000 in 2010 
to 111.1 cases per 100,000 in 2015. The estimated MSW rate increased slightly in 5 SSuN 
sites and declined substantially in Philadelphia between 2010 and 2015. There was 
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considerable variation in rates among MSW by site with the highest estimated rate in 
Philadelphia in 2012 (525 per 100,000) and the lowest estimated rate for MSW in 
Washington State in 2011 (28 cases per 100,000). Among women, rates were calculated 
based on reported cases rather than on estimates; among all sites, the annual reported rate 
among women increased from 103 cases per 100,000 in 2010 to 144 cases per 100,000 in 
2015. The rate of reported cases among women decreased in 3 SSuN sites, Baltimore, 
Philadelphia, and New York City, between 2010 and 2015.
Overall, the change in estimated rates among MSW and among women across the study 
period were relatively modest in magnitude, whereas the estimated rates among MSM 
increased substantially more (Fig. 1). Consequently, the ratio between MSM rates and those 
of MSW and women increased markedly across the period, with the most pronounced 
change occurring between 2013 and 2015. Between 2010 and 2015, the MSM-to-women 
rate ratio increased from 13:1 to 24:1, and the MSM-to-MSW rate ratio increased from 16:1 
to 31:1. In all years, the rate ratio between MSM and MSW was higher than that observed 
between MSM and women. In 2015, we estimated a 24-fold difference in gonorrhea case 
rates between MSM and women and a 31-fold difference between MSM and MSW rates.
DISCUSSION
To our knowledge, these data from the STD Surveillance Network provide the first 
population-based estimates of the rate of reported cases of gonorrhea among gay, bisexual, 
and other MSM across multiple jurisdictions in the United States. Moreover, our analysis 
demonstrates a sharp increase in the estimated case rate among MSM in these 6 jurisdictions 
between 2010 and 2015. The rate among women and among MSW across these 
jurisdictions, however, showed less marked increases or even slight decreases during the 
same period. Rate ratios comparing rates among MSM to heterosexual males and to women 
reveal an important, and apparently growing, inequality in the burden of disease among 
MSM versus heterosexual men and women.
We were able to characterize cases and case rates among MSM in SSuN jurisdictions 
because the proportion of male cases reporting same-sex partnerships was estimated through 
enhanced surveillance on a representative sample of all reported cases. Moreover, estimates 
of the size of the MSM population—at the needed level of geographic granularity—are now 
available to facilitate estimation of population-adjusted case rates. Had we used overall 
national estimates of the number of men in the adult population who are MSM rather than 
jurisdiction-specific data, we would have significantly underestimated the size of the MSM 
population, particularly in our city-level jurisdictions, and consequently overestimated case 
rates.
Although some portion of the observed increase in reported MSM cases may be attributable 
to increased screening at nongenital anatomic sites, which has become a recommended 
standard of care for MSM sexual health,9 sharp increases in male gonorrhea cases noted 
elsewhere in the United States,1 as well as documented increases in the incidence of syphilis 
among MSM, provide additional evidence that our observations of increased gonorrhea 
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diagnoses among MSM in SSuN jurisdictions may reflect an important, emergent trend in 
the epidemiology of gonorrhea.
Given the higher prevalence of HIV infection among MSM, an increase in gonorrhea in this 
population may have important implications for HIV transmission. Diagnoses of STDs 
among MSM present sentinel opportunities for HIV case finding as well as for assuring 
linkage of patients known to be living with diagnosed HIV to HIV-primary care. Better 
characterization of the rate of gonorrhea and other STDs among MSM may also contribute 
directly to public health actions to prevent HIV transmission. MSM living with diagnosed 
HIV who are diagnosed with gonorrhea should be engaged (or reengaged) with HIV care 
including viral suppressive therapy to reduce the risk of HIV transmission. Men who have 
sex with men with gonorrhea who are not known to be living with diagnosed HIV are 
potential candidates for interventions such as preexposure and postexposure prophylaxis to 
reduce the likelihood of HIV infection.10
Moreover, our observations of increasing gonorrhea diagnoses are for MSM broadly 
construed; we chose to use a broadly inclusive definition of MSM. Our case data include 
information on bisexual and non–gay-identified men who may also have female partners in 
addition to their male partners. The potential for bridging between higher-prevalence MSM 
networks and lower-prevalence heterosexual populations, contributing to a more generalized 
gonorrhea epidemic, is a clear epidemiologic concern. Additionally, MSM may be at greater 
risk for acquisition of gonococcal infections with reduced susceptibility to antibiotics, 
making it especially important to address this population with both enhanced surveillance, as 
well as intensified, MSM-appropriate disease prevention efforts.11,12
There are limitations to SSuN data; estimates of the proportion of cases attributable to MSM 
are based on a random sample of cases interviewed in each jurisdiction. Although we 
adjusted for differential response rates by sex and age group, there may be unmeasured 
biases present in our data. It is possible that either MSM or non-MSM were more or less 
likely to respond to attempts by public health staff to contact them for an interview. This 
could result in either an underestimate or overestimate of the proportion of gonorrhea cases 
occurring among MSM. We have no evidence to suggest bias in either direction, but because 
information on sex of sex partners is generally not ascertained for cases who are not 
interviewed by public health staff, we have no way to independently assess response rates 
among MSM.
Additionally, confidence intervals associated with our estimates of MSM vary in magnitude 
depending on the fraction of cases sampled and response rate. We performed a sensitivity 
analysis assuming the lower value of the 95% confidence interval for the proportion of male 
cases attributable to MSM for 2015 (53.7% of males vs the midpoint of 61.6%), and still 
found a 20-fold and 23-fold difference in the rates between MSM, and women and MSW, 
respectively, using these lower estimates. No confidence intervals or standard errors are as 
yet available for the published MSM denominator estimates so we were unable to conduct a 
fuller sensitivity analysis. We did not have interview data for 2014 due to implementation of 
new SSuN data management protocols, but these changes were unrelated to methods of case 
sampling, patient recruitment and ascertainment of sex of sex partners. Interview questions 
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related to sex of partners and sexual orientation remained consistent across the entire period 
in these 6 jurisdictions. Our annual estimates for 2013, and again for 2015, are based on 6 
months of data rather than for a full year as for 2010 to 2012. For the purposes of visualizing 
our data in Figure 1, we assumed that the trend between 2013 and 2015 was linear (shown as 
a dashed line in the figure), which might have masked significant variation across this gap in 
data.
Many jurisdictions in the United States are increasing both the screening frequency and 
range of anatomic sites tested among MSM presenting for care in STD clinics in response to 
national recommendations.9 Increased screening of nongenital sites for MSM may be 
identifying a previously undiagnosed, asymptomatic burden of anorectal or pharyngeal 
infections, leading to an increase in reported cases. We surmise that some of the increased 
burden of disease we detected among MSM during our study period is likely attributable to 
increased anorectal and pharyngeal testing. Yet, arguing against additional screening 
explaining all or most of the change in the burden of disease we detected among MSM, only 
a modest decrease in the proportion of all male cases reporting symptoms was observed 
during this same period (67.7% of cases in 2010 to 57.9% in 2015, data not shown).
Finally, SSuN jurisdictions were not selected to be representative of all states, cities and 
counties in the United States. There is likely considerable variation in these measures across 
the national landscape, but because there is considerable travel and mobility in all 
populations, and increases in male gonorrhea have been observed in many other locations 
nationally, we posit that these findings may be suggestive of trends elsewhere. Despite 
limitations, these data demonstrate an increasing trend in reported gonorrhea cases among 
MSM in collaborating SSuN sites and highlight the need for additional focus on ascertaining 
sex of sex partner information on cases reported in other areas experiencing significant 
increases in male gonorrhea cases.
CONCLUSIONS
Gonorrhea case rates among MSM increased in a diverse group of US jurisdictions between 
2010 and 2015. The burden of gonorrhea in this population in 2015 was estimated to be 
greater than 30 times that observed among MSW and 24 times that of women. Inequality in 
the burden of disease for MSM of this magnitude, documented now for both syphilis and 
gonorrhea, challenges the public health community to better address the prevention, 
diagnostic, and treatment needs of this population in new and innovative ways and highlights 
the need for a more robust local, state, and national response to a particularly acute sexual 
health inequity in an historically marginalized population. Continuing development and use 
of state, county, and local area estimates of the size of the MSM population (with 
appropriate standard errors as these become available), as well as efforts to ascertain or 
estimate the proportion of reported cases occurring among MSM are critical for furthering 
our understanding of the changing epidemiology of gonorrhea, for improving MSM health 
outcomes and for preventing a more generalized national gonorrhea epidemic.
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Gonorrhea—trend in estimated gonorrhea case rate among MSM, MSW and Women*, 6 
SSuN Sites, 2010–2015.
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